KR20220148883A - 세포 노화 억제제, 생체 조직 수복 촉진제, 유전자 발현 조절제 및 제조 방법 - Google Patents
세포 노화 억제제, 생체 조직 수복 촉진제, 유전자 발현 조절제 및 제조 방법 Download PDFInfo
- Publication number
- KR20220148883A KR20220148883A KR1020227034047A KR20227034047A KR20220148883A KR 20220148883 A KR20220148883 A KR 20220148883A KR 1020227034047 A KR1020227034047 A KR 1020227034047A KR 20227034047 A KR20227034047 A KR 20227034047A KR 20220148883 A KR20220148883 A KR 20220148883A
- Authority
- KR
- South Korea
- Prior art keywords
- gene
- tissue repair
- action
- derived
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020065052 | 2020-03-31 | ||
| JPJP-P-2020-065052 | 2020-03-31 | ||
| PCT/JP2021/011546 WO2021200299A1 (ja) | 2020-03-31 | 2021-03-19 | 細胞老化抑制剤、生体組織修復促進剤、遺伝子発現調節剤及び製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220148883A true KR20220148883A (ko) | 2022-11-07 |
Family
ID=77928040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227034047A Pending KR20220148883A (ko) | 2020-03-31 | 2021-03-19 | 세포 노화 억제제, 생체 조직 수복 촉진제, 유전자 발현 조절제 및 제조 방법 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP7478227B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220148883A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021200299A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7371975B1 (ja) * | 2022-09-27 | 2023-10-31 | セルソース株式会社 | 細胞外小胞の製造方法及び細胞外小胞含有組成物 |
| JP7433685B1 (ja) | 2023-06-09 | 2024-02-20 | 日生バイオ株式会社 | 真皮線維芽細胞の機能賦活用剤及びそれを含んでなる化粧品 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016088689A1 (ja) | 2014-12-05 | 2016-06-09 | 和光純薬工業株式会社 | Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108392494A (zh) | 2018-05-15 | 2018-08-14 | 江苏大学 | 人脐带间质干细胞分泌的exosome在制备修复皮肤紫外线损伤的药物中的应用 |
| CN109172859A (zh) * | 2018-09-06 | 2019-01-11 | 上海长海医院 | 人干细胞来源外泌体复合外源性透明质酸在制备皮肤创面缺损修复药物或材料中的应用 |
| CN110548001A (zh) * | 2019-09-06 | 2019-12-10 | 沈阳细胞治疗工程技术研发中心有限公司 | 一种含脐带间充质干细胞外泌体的修复抗衰护肤品 |
-
2021
- 2021-03-19 JP JP2022511936A patent/JP7478227B2/ja active Active
- 2021-03-19 WO PCT/JP2021/011546 patent/WO2021200299A1/ja not_active Ceased
- 2021-03-19 KR KR1020227034047A patent/KR20220148883A/ko active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016088689A1 (ja) | 2014-12-05 | 2016-06-09 | 和光純薬工業株式会社 | Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット |
Non-Patent Citations (4)
| Title |
|---|
| 비특허문헌 1: Mathieu M, Martin-Jaular L, Lavieu G, Thery C(2019) Nat Cell Biol, 21(1):9-17 |
| 비특허문헌 2: Arsalan S et al. STEM CELLS AND DEVELOPMENT Volume 24, Number 14, 2015 |
| 비특허문헌 3: Bocheng Zhang et al. Cell Transplantation Volume 29:1-14 |
| 비특허문헌 4: Connie S. Chamberlain al. Stem Cells. 2021; 39:55-61. |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7478227B2 (ja) | 2024-05-02 |
| WO2021200299A1 (ja) | 2021-10-07 |
| JPWO2021200299A1 (cg-RX-API-DMAC7.html) | 2021-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takov et al. | Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential | |
| EP3029061B1 (en) | Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage | |
| Blaber et al. | Analysis of in vitro secretion profiles from adipose-derived cell populations | |
| KR101655780B1 (ko) | 클로날 중간엽 줄기세포를 포함하는, 아토피성 피부염 예방 또는 치료용 약학적 조성물 | |
| KR102127527B1 (ko) | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도 | |
| KR20220024060A (ko) | 질환 치료용 엑소좀 | |
| KR20200083596A (ko) | 엑소좀을 단리시키기 위한 태반의 배양 | |
| HK1256111A1 (zh) | 干细胞衍生的含有大量生长因子的外来体 | |
| JP7449590B2 (ja) | 間葉系幹細胞由来のエキソソーム生産方法およびこれから製造された培養液 | |
| Hamid et al. | Cardiac mesenchymal stem cells promote fibrosis and remodeling in heart failure: role of PDGF signaling | |
| EP3515459A1 (en) | Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders | |
| ES2914692T3 (es) | Células madre adhesivas derivadas de cordón umbilical mejoradas, método de preparación para las mismas, y uso de las mismas | |
| US20220362290A1 (en) | Anti-fibrosis agent and method of producing extracellular vesicle having anti-fibrosis action | |
| US20230220423A1 (en) | Extracellular Vesicles Engineered to Be Loaded with Distinct RNA Cargo for Improved Therapeutic Efficacy | |
| KR20190003399A (ko) | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부 섬유증 개선 용도 | |
| CN115397445A (zh) | 包含来源于凝血酶处理的干细胞的外泌体的用于预防或治疗糖尿病性皮肤病的组合物 | |
| JP7478227B2 (ja) | 細胞老化抑制剤、生体組織修復促進剤、遺伝子発現調節剤及び製造方法 | |
| Jiao et al. | Stimulation of mouse hair regrowth by exosomes derived from human umbilical cord mesenchymal stem cells | |
| Kim et al. | Canine amniotic membrane-derived mesenchymal stem cells ameliorate atopic dermatitis through regeneration and immunomodulation | |
| JP2024520415A (ja) | 線維芽細胞及び線維芽細胞由来産物を用いる脱毛症治療のための方法及び組成物 | |
| Kong et al. | The crosstalk among macrophages, chondrocytes and mesenchymal stem cells in osteoarthritis: the role of extracellular vesicles | |
| Tilotta et al. | Wharton's Jelly Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Attenuate Intervertebral Disc Degeneration Under Inflammatory Stress in an In Vitro 3D Culture System | |
| KR20250090208A (ko) | 혼합 엑소좀을 유효성분으로 포함하는 조성물 및 이의 용도 | |
| EP3903793A1 (en) | Pharmaceutical composition comprising clonal stem cell for prevention or treatment of atopic dermatitis | |
| US20230126684A1 (en) | Anti-inflammatory agent and method of producing extracellular vesicle having anti-inflammatory action |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| R13 | Change to the name of applicant or owner recorded |
Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |